ARX vs CGS

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

56MEDIUM

CGS

COGSTATE FPO [CGS]

57MEDIUM

Score Breakdown

ARX CGS
Technical
48
61
Catalyst
55
55
Sentiment
50
50
Fundamental
99
99
Momentum
46
64
Risk Gate
50
45

Key Metrics

ARX Metric CGS
$191.1MMarket Cap$523.4M
144KAvg Volume (20d)699K
N/AShort Interest+0.0%
$0.80052-Week High$3.230
$0.49552-Week Low$1.690
+0.0%Daily Change-0.3%
$0.540Reference Price$3.070
+4.9%ROE+22.5%
+4.5%Profit Margin+19.5%

Active Signals

ARX Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is losing steam
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 4.4% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it

CGS Signals

Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Moderate P/S ratio (8.6x)
Moderate revenue growth (+16%)
Piotroski F-Score strong (8/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Near 52-week high (90% of range)

Ask Scout AI to compare ARX and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ATX vs CGS →AVE vs EYE →BLS vs CGS →CGS vs IIQ →CGS vs LDX →
ARX Full Analysis → CGS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).